The trademark application was filed by EXACTIS INNOVATION, a corporation established under the laws of Canada (the "Applicant"). The application was published for oppositions on November 5, 2020, and it was registered by office on February 12, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on June 3, 2024.
Goods And Services
The mark was filed in class 35 with Promoting collaboration and the exchange of information and resources within the scientific, research, medical, clinical and private communities to achieve advances in the field of cancer treatment.
The mark was filed in class 36 with Sponsoring clinical and translational trials in the field of cancer treatment.
The mark was filed in class 38 with Providing access to a biobank of human biological and tissue samples.
The mark was filed in class 42 with following description of goods:
Management of clinical and translational trials in the field of cancer treatment
Medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients
Medical and scientific research in the field of cancer treatment
Providing clinical trial information, research information, pharmacoeconomic information, pharmacovigilance information, all pertaining to cancer and its treatment.